Article Data

  • Views 213
  • Dowloads 141

Case Reports

Open Access

Recurrent uterine tumor resembling ovarian sex cord tumor: clinicopathological and immunohistochemical analysis of a case report and a literature review

  • Xiao-qiang Wei1
  • Meng Tang2
  • Ben-xu Ma3
  • Li-li Liu4
  • Shu-ping Zhao1,*,

1Department of Gynecology, Qingdao Women and Children’s Hospital, Women and Children’s Hospital of Qingdao University, 266011 Qingdao, Shandong, China

2Department of Thoracic Surgery, Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, Shandong, China

3Department of Acupuncture and Moxibustion, Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, Shandong, China

4Department of Pathology, Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, Shandong, China

DOI: 10.22514/ejgo.2024.109 Vol.45,Issue 5,October 2024 pp.197-203

Submitted: 17 November 2022 Accepted: 02 March 2023

Published: 15 October 2024

*Corresponding Author(s): Shu-ping Zhao E-mail: manuscription@sina.com

Abstract

Uterine tumor resembling ovarian sex-cord tumor (UTROSCT) is a rare gynecological tumor which has undetermined pathogenesis but with distinct polyphenotypic immuno-histochemical expressions. According to the limited cases and follow-up information in the relevant literatures, most of the tumors exhibit indolent or low malignant clinical course and the outcomes of the patients with the tumors generally have a good ending. But for the subset of UTROSCT with aggressive characters, the outcomes of the patients with recurrent neoplasm were not always satisfactory. This case report reported neoplasm recurrence in the pelvic cavity after 53 months of surgery and irregular follow-up. The recurrent neoplasm grew in an invasive manner. The arrangement of the recurrent neoplasm cells was closer, the nucleus atypia was more pronounced, and the cells demonstrated a more briskly mitotic activity (10 mitotic figures per ten high-powered fields, 10 mitotic figures/10 HPF). The Ki67 index increased significantly. Both the clinical characteristics and histological morphology of the recurrent neoplastic cells showed a more malignant behavior. The patient received a palliative resection of pelvic mass and bilateral oophorectomy, and she died of intestinal obstruction caused by the recurrent disease 9 months postoperatively. UTROSCT with characters for the aggressive process should deserve more attention. Once it relapses, the recurrent tumor of UTROSCT might show a higher malignant tendency and a poor prognosis. Gynecologists and pathologists need to analyze the clinical and histologic assessment in collaboration and better evaluate UTROSCT with aggressive characters.


Keywords

UTROSCT; Recurrence; Aggressive characters; Case report


Cite and Share

Xiao-qiang Wei,Meng Tang,Ben-xu Ma,Li-li Liu,Shu-ping Zhao. Recurrent uterine tumor resembling ovarian sex cord tumor: clinicopathological and immunohistochemical analysis of a case report and a literature review. European Journal of Gynaecological Oncology. 2024. 45(5);197-203.

References

[1] Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023; 21: 181–209.

[2] Hurrell DP, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers. Journal of Clinical Pathology. 2007; 60: 1148–1154.

[3] Moore M, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow-up. Histopathology. 2017; 71: 751–759.

[4] O’Meara AC, Giger OT, Kurrer M, Schaer G. Case report: recurrence of a uterine tumor resembling ovarian sex-cord tumor. Gynecologic Oncology. 2009; 114: 140–142.

[5] Marrucci O, Nicoletti P, Mauriello A, Facchetti S, Patrizi L, Ticconi C, et al. Uterine tumor resembling ovarian sex cord tumors type II with vaginal vault recurrence. Case Reports in Obstetrics and Gynecology. 2019; 2019: 1–4.

[6] Kuznicki ML, Robertson SE, Hakam A, Shahzad MM. Metastatic uterine tumor resembling ovarian sex cord tumor: a case report and review of the literature. Gynecologic Oncology Reports. 2017; 22: 64–68.

[7] Kondo Y, Sakaguchi S, Mikubo M, Naito M, Shiomi K, Ohbu M, et al. Lung metastases of a uterine tumor resembling ovarian sex-cord tumor: report of a rare case. Diagnostic Cytopathology. 2018; 46: 88–91.

[8] Cömert GK, Kiliç Ç, Çavuşoğlu D, Türkmen O, Karalok A, Turan T, et al. Recurrence in uterine tumors with ovarian sex-cord tumor resemblance: a case report and systematic review. Turkish Journal of Pathology. 2018; 34: 225–233.

[9] Chang B, Bai Q, Liang L, Ge H, Yao Q. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review. Diagnostic Pathology. 2020; 15: 110.

[10] Mathur S, Kaur K, Rajeshwari M, Gurung N, Kumar H, Sharma M, et al. Uterine tumor resembling ovarian sex cord tumor: a series of six cases displaying varied histopathological patterns and clinical profiles. Indian Journal of Pathology and Microbiology. 2020; 63: 81.

[11] Goebel EA, Hernandez Bonilla S, Dong F, Dickson BC, Hoang LN, Hardisson D, et al. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent NCOA1-3 Rearrangement. American Journal of Surgical Pathology. 2020; 44: 30–42.

[12] Bennett JA, Lastra RR, Barroeta JE, Parilla M, Galbo F, Wanjari P, et al. Uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT): a series of 3 cases with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions. American Journal of Surgical Pathology. 2020; 44: 1563–1572.

[13] Liu CY, Shen Y, Zhao JG, Qu PP. Clinical experience of uterine tumors resembling ovarian sex cord tumors: a clinicopathological analysis of 6 cases. International Journal of Clinical and Experimental Pathology. 2015; 8: 4158–64.

[14] Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M, Sawada K, et al. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014; 181: 163–170.

[15] Irving JA, Carinelli S, Prat J. Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Modern Pathology. 2006; 19: 17–24.

[16] Pradhan D, Mohanty SK. Uterine tumors resembling ovarian sex cord tumors. Archives of Pathology & Laboratory Medicine. 2013; 137: 1832–1836.

[17] Shen Y, Fan L, Chanda K, Ren M. Uterine tumors resembling ovarian sex-cord tumor: a case report and literature review. Journal of Cancer Research and Therapeutics. 2018; 14: 1209.

[18] Giordano G, Lombardi, Brigati, Mancini, Silini. Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors. International Journal of Gynecological Pathology. 2010; 29: 459–467.

[19] Zhang X, Zou S, Gao B, Qu W. Uterine tumor resembling ovarian sex cord tumor: a clinicopathological and immunohistochemical analysis of two cases and a literature review. Journal of International Medical Research. 2019; 47: 1339–1347.

[20] Hashmi A, Faridi N, Edhi M, Khan M. Uterine tumor resembling ovarian sex cord tumor (UTROSCT), case report with literature review. International Archives of Medicine. 2014; 7: 47.

[21] McGettigan CP, Armstrong G, Saleh N, Slade RJ. Malignant melanoma of the uterus diagnosed at hysteroscopy. Journal of Obstetrics and Gynaecology. 2006; 26: 383–385.

[22] Krishnamurthy S, Jungbluth AA, Busam KJ, Rosai J. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. The American Journal of Surgical Pathology. 1998; 22: 1078–1082.

[23] Umeda S, Tateno M, Miyagi E, Sakurai K, Tanaka R, Tateishi Y, et al. Uterine tumors resembling ovarian sex cord tumors (UTROSCT) with metastasis: clinicopathological study of two cases. International Journal of Clinical and Experimental Pathology. 2014; 7: 1051–1059.

[24] Hauptmann S, Nadjari B, Kraus J, Turnwald W, Dietel M. Uterine tumor resembling ovarian sex-cord tumor—a case report and review of the literature. Virchows Archiv. 2001; 439: 97–101.

[25] Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009; 137: 413–431.

[26] CETINKAYA N, BAS S, CUYLAN ZF, ERDEM O, ERKAYA S, GUNGOR T. Uterine tumors resembling ovarian sex cord tumors: a case report and literature review. Oncology Letters. 2016; 11: 1496–1498.

[27] Berretta R, Patrelli TS, Fadda GM, Merisio C, Gramellini D, Nardelli GB. Uterine tumors resembling ovarian sex cord tumors. International Journal of Gynecological Cancer. 2009; 19: 808–810.

[28] Watrowski R, Jäger C, Möckel J, Kurz P, Schmidt D, Freudenberg N. Hysteroscopic treatment of uterine tumor resembling ovarian sex cord-like tumor (UTROSCT). Gynecological Endocrinology. 2015; 31: 856–9.

[29] Hillard J. Conservative management of a uterine tumor resembling an ovarian sex cord-stromal tumor. Gynecologic Oncology. 2004; 92: 347–352.

[30] Carbone MV, Cavaliere AF, Fedele C, Vidiri A, Aciuolo D, Zannoni G, et al. Uterine tumor resembling ovarian sex-cord tumor: conservative surgery with successful delivery and case series. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 256: 326–332.

[31] Sato M, Yano M, Sato S, Aoyagi Y, Aso S, Matsumoto H, et al. Uterine tumor resembling ovarian sex-cord tumor (UTROSCT) with sarcomatous features without recurrence after extended radical surgery. Medicine. 2020; 99: e19166.

[32] Lee C, Kao Y, Lee W, Hsiao Y, Lu T, Chu C, et al. Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation. American Journal of Surgical Pathology. 2019; 43: 928–942.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top